April 30, 2009 – Agenda
|
| |
1:30 – 2:00
| Registration
|
| 2:00 – 2:20 | Welcome
James C. Mullen, President and CEO, Biogen Idec
Bob Buderi, Founder and Editor in Chief, Xconomy |
| 2:20 – 2:40 | Case Study: Zafgen
Thomas Hughes, President and CEO, Zafgen
Maria Rupnick, Co-Founder, Zafgen, and Instructor of Medicine, Harvard Medical School |
| 2:40 – 3:00 | Case Study: Forma Therapeutics
Steven Tregay, Founder, President, and CEO, Forma Therapeutics |
| 3:00 – 4:00 | Panel: New Frontiers for Public Biotechs
Gilmore N. O’Neill, Senior Director, Experimental Neurology, Biogen Idec
Sam Wadsworth, Group Vice President of Translational Research, Genzyme
Eric Olson, VP of Program and Portfolio Management, Vertex Pharmaceuticals
Michelle Dipp (moderator), Vice President and Head of the U.S. Centre of Excellence for External Drug Discovery, GlaxoSmithKline |
| 4:00 – 4:25 | Networking Break |
| 4:25 – 4:45 | Case Study: Ironwood Pharmaceuticals
Peter Hecht, CEO, Ironwood Pharmaceuticals |
| 4:45 – 5:05 | Case Study: GlycoFi and Adimab
Tillman Gerngross, Co-founder and scientific advisory board chair, GlycoFi, Co-founder and CEO, Adimab, and Professor of Engineering, Dartmouth |
| 5:05 – 5:45 | Fireside Chat
Walter Gilbert, General Partner, BioVentures Investors, and University Professor Emeritus, Harvard
George Church, Professor of Genetics, Director of the Center for Computational Genetics, Harvard Medical School
James Collins (moderator), University Professor and Professor of Biomedical Engineering, Boston University |
5:45 – 7:00
| Networking Reception
|
| |
| CLICK HERE FOR MORE DETAILS AND TO REGISTER. |
